Introduction
The concept of immunosurveillance against cancer (1) endures despite controversies (2, 3) . Attention has been focused lately on natural killer (NK)' cells (4) as potential custodians of surveillance against neoplasia. Despite considerable research, the relevance of natural killing in surveillance against neoplasia has been difficult to determine due largely to the use of prototype target cell lines or cells derived from overt tumors that presumably developed after escaping immunosurveillance. The role of natural killing in surveillance against cancer would be more ideally approached with autologous targets that were transformed in vitro. Using such an approach, we show here the existence of natural killing in blood lymphocytes, as defined operationally and by phenotypic characteristics, against an in vitro transformed tumorigenic autologous human cell line, VIP-F:T. In this system, cytotoxicity (CTX) against the autologous transformed target is inducible with interferon (IFN), interleukin-2 (IL-2), and by in vitro co-culture (IVC) against the autologous transformed target in the presence of exogenous IL-2. We further show that, while IFN or IL-2 induces nonspecific killing, IVC in IL-2 generates cytotoxic effectors which exhibit NK cell phenotype and express specificity for VIP-F:T target receptors distinct from target receptors on autologous non-transformed fibroblasts and on the NK prototype target K562. In addition, data is presented on in vivo corroboration of the cytotoxicity of the in vitro sensitized effector cells, which shows their ability to impart transplantation rejection of tumorigenic challenge with the VIP-F:T cells in nude mice.
Methods
Target cells. The VIP-F:T line, developed in our laboratory as a spontaneous in vitro transformation of cultured normal human skin fibroblasts that grow in an anchorage-independent fashion in soft agar and produce tumors histologically and ultrastructurally consistent with sarcomas in nude mice, has been partially described (5) . A detailed characterization (including HLA types) of the VIP-F:T line, VIP-F:T.3 (a clone of VIP-F:T), and another autologous normal fibroblast line, Pen-F2, has been presented elsewhere (6) . The Pen-F2 line grows as a contact-inhibited monolayer, shows no anchorage-independent growth, 1 . Abbreviations used in this paper: CMC, cell-mediated cytotoxicity; CTL, cytotoxic T lymphocytes; CTX, cytotoxicity; FACS, fluorescence activated cell sorter; IFN, interferon; IL-2, interleukin-2; IVC, in vitro co-culture; LAK, lymphokine activated killing; LGL, large granular lymphocytes; NK, natural killer; rIFN-'y, recombinant interferon-y; rIL-2, recombinant interleukin-2.
and is not tumorigenic in nude mice. The melanoma line, VIP, derived from the same patient from whom the in vitro transformed fibroblast line VIP-F:T was also derived, has been described (5, 6) . The melanoma line VIP expresses Ia antigen constitutively, whereas the VIP-F:T line exhibits no Ia antigen. Several other melanoma lines that were established in our laboratory have also been used. Tissue culture was performed in Hams F-10 media (Gibco Laboratories, Grand Island, NY) that was supplemented with 10% fetal calf serum (Gibco Laboratories).
Interleukin 2. The partially purified IL-2 (Electro-Nucleonics, Silver Spring, MD) used in these experiments had no detectable IFN-a or IFN-y activity (tested in standard IFN bioassay in the Interferon Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, courtesy of Mathilde Krim). In addition, interferon-free IL-2 that was purified from conditioned media of the Gibbon leukemia cell line MLA-144 (7) (a gift of Harvey Rabin, National Cancer Institute, Frederick, MD) and recombinant DNA-produced IL-2 (Amgen, Thousand Oaks, CA) were also used in selected experiments.
Effector cells. Peripheral blood mononuclear cells were isolated in Ficoll-Hypaque gradient and depleted of macrophages (referred to henceforth as peripheral blood lymphocytes [PBL]) by 2-h adherence in plastic flasks as described earlier (5) . Large granular lymphocytes (LGL), which were recently described as prime mediators of NK activity (4, 8) , were isolated by standard technique (8) from macrophagedepleted PBL in the interface between the first and second layers of six 2.5-ml gradients of Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) ranging from 45% (R.I. 1.3432) and 57.5% (R.I. In vitro co-culture. IVC of effector cells was carried out with unfractionated blood mononuclear cells in co-culture against irradiated target cells. Briefly, effector cells (1 X 106/ml) were co-cultured with irradiated (4,500 rad) autologous or allogeneic targets (1 X 104/ml) in Hams F-10 medium and IL-2 (5 X 102 U/ml). Cultures were fed with IL-2 containing medium three times weekly.
Microcytotoxicity (CMC) assay. The 4 h 51Cr-release assay has been described earlier (5) .
Cold target competition assay. The standard technique of inhibition of cytotoxicity by cold target interaction has been followed (9) . Briefly, CMC assays were set up in the usual manner. Immediately after addition of the effector cells, unlabeled (cold) targets of various derivations were added at different concentrations to a constant number of labeled targets. In each assay, dose-response analysis of percentage inhibition was carried out. Although the cytotoxic activity by the PBL and the LGL against autologous VIP-F:T cells could be augmented by treatment with IFN-a or IL-2 for 2 h of incubation (data not shown), higher levels of activity were achieved after overnight incubation of the effector cells with either mediator. As shown in Fig. 3 , high levels of CTX against VIP-F:T were generated following in vitro sensitization of the unfractionated effector cells with VIP-F:T cells in the presence of partially purified IL-2 or by culturing the effector cells in the presence of IL-2 alone. Although CTX of the effector cells reached peak levels by 7 d, whether they were cultured in IL-2 alone or co-cultured with the VIP-F:T targets in the presence of IL-2, the levels of cytotoxicity generated by in vitro sensitization in IL-2 were significantly higher at 24 and 72 h of co-culture. CTX generated under either condition could be maintained for several weeks by culturing the effector cells in medium containing IL-2, after which activities generated under either condition declined (Fig.  3 ). Interestingly, when tested for natural killing against the autologous melanoma cells VIP, both PBL and LGL showed only marginal levels of CTX against the VIP cells (individual data not shown).
Phenotype of effector cell responding to IVC. The nature of the effector cells responding to IVC in the presence of IL-2 was examined by sorting effector cells by negative and positive selection in a FACS using monoclonal Leu-7 (HNK-1), Leu-1 la, OKT3, OKT4, or OKT8 antisera. Fig. 4 shows examples of some populations of cells that were sorted 1 w after IVC. The cytotoxic activity was restricted to a population of cells bearing the Leu-7 and Leu-l la phenotypes (Fig. 5) . As shown in Fig. 5 A, the removal of the Leu-7+ and Leu-l la+ cells eliminated the CTX almost completely, while the removal of the T4 and T8+ cells enhanced the level of CTX by enriching the NK cells in the effector population. Interestingly, the positively sorted Leu-7+ and Leu-1 la+ cells immediately after sorting exhibited activity levels considerably lower than that of the unsorted population ( Fig. 5 B) ; this was possibly due to modulation of the respective molecule from the cell surface. After overnight culture, the Leu-7 and Leu-l la+ fractions showed higher levels of killing (Fig. 5 C) .
Several other sorting experiments were performed at different kinetic points of the IVC protocol. Abrogation of Specificities of cytotoxicity by the effector cells activated in IVC protocol. The specificities of the cytotoxic activities generated by in vitro sensitization in the presence of IL-2, or generated in IL-2 alone, were examined in cold target competition experiments (9) . Interestingly, IVC against VIP-F:T in the presence of IL-2 generated a population of effector cells that showed restricted specificity when tested against VIP-F:T (Fig. 6) . Neither the autologous nontransformed fibroblasts nor the NK prototype target K562 effectively competed against the VIP-F:T target. When the same effector cells were tested against K562, no restricted specificity was seen (Fig. 6) . The tion, assayed immediately after sorting.) (C: Same (as in Fig. 5 B) populations of antigen plus populations assayed for cytotoxicity after overnight culture.
cytotoxic activities generated in IL-2 alone did not show restricted specificity when tested against VIP-F:T and K562 in reciprocal experiments (Fig. 6, C and D culture in 20% IL-2, the positively sorted Leu-l la+ cells showed significant levels of cytotoxicities (Fig. 8 A) , as well as target receptor specificity for the autologous target VIP-F:T (Fig. 8 B) .
In vivo protection by IVC effector cells against tumorigenic challenge by VIP-F:T target. The results of an in vivo tumor cell neutralization experiment is shown in Table III . As can be seen, the effector cells generated in IVC protocol clearly demonstrated protection of the nude mice from tumorigenic challenge with the VIP-F:T.3 cells. The cloned line was used in the transplantation experiment to avoid the potential problem of heterogeneity within the parent line. The cloned target cells were quite sensitive to lysis by the effector cells in vitro (data not shown). Table IV shows the effect of removal of the Leu-7+ cells on the protective effect of the in vitro sensitized effector cells. In order to assure absolute sterility, the Leu-7+ cells were removed by complement induced lysis of Leu-7 antibody coated cells. It is of interest that removal of the Leu-7+ cells abrogated the protective ability of the co-culture activated effector cells against tumorgenic challenge, while the effector population, incubated with complement withour prior antibody incubation, showed protection at an effector to target ratio of 10:1. (10) . Admittedly, the question of target receptor specificity for NK cells has been elusive. A critical evaluation of specificities of NK cell mediated cytotoxicities has been hampered by a number of factors, two of which have been the lack of tumor models in which immune response by NK cells could be examined in its true, albeit theoretical, perspective and the extreme heterogeneity within the NK population. In this respect, this type of approach (i.e., studies of cytotoxic response to in vitro transformed autologous targets) offers a unique, if not ideal, opportunity to address these issues. In reference to LAK as a possible explanation of the activity inducible in IVC, two major points clearly suggest that the IVC protocol described in this communication generates a response which, by phenotypic and functional definition, is not an LAK response. LAK is mediated by a population bearing other than the Leu-7 phenotype; and LAK, as shown by Grim et al. (10) and confirmed in our studies (Fig. 6 C) , shows no restricted specificity. The cytotoxic response generated in IVC in this study was clearly exhibited by a population bearing Leu-7 and Leu-l la phenotypes (by far the best phenotypic markers presently available for human NK cells); and such activity, at least by a population within the lineage broadly defined as NK, exhibited specificity for VIP-F:T target receptors distinguishable from that associated with the prototype NK target K562 or with the nontransformed autologous fibroblasts.
Finally, our data on transplantation rejection lend considerable credibility to the cytotoxicities observed in in vitro assays and confirm the in vitro observation of the effect of NK cell depletion on cytotoxicity. The data also point out that similar approaches employing in vitro transformed tumorigenic targets (a goal achievable by presently available technology, such as transfection and chemically induced transformation) offer opportunities to gain valuable insight into mechanisms of immunosurveillance against cancer.
